Cardiovascular regenerative medicine is an emerging field focused on repairing and restoring damaged heart tissues using cutting-edge biological approaches. Stem cell therapy has shown promise in regenerating cardiomyocytes and improving heart function in patients with heart failure or myocardial infarction. Researchers are also exploring the potential of tissue engineering to create bioengineered heart patches for targeted repair. Additionally, advancements in gene editing techniques like CRISPR are being investigated to correct genetic mutations associated with cardiovascular disorders. By combining biomaterials, cellular therapies, and innovative delivery systems, cardiovascular regenerative medicine aims to revolutionize treatment outcomes and offer hope to patients suffering from severe cardiac conditions.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India